8 results on '"Schandelmaier"'
Search Results
2. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
- Author
-
Gryaznov, Dmitry, Odutayo, Ayodele, von Niederhäusern, Belinda, Speich, Benjamin, Kasenda, Benjamin, Ojeda-Ruiz, Elena, Blümle, Anette, Schandelmaier, Stefan, Mertz, Dominik, Tomonaga, Yuki, Amstutz, Alain, Pauli-Magnus, Christiane, Gloy, Viktoria, Bischoff, Karin, Wollmann, Katharina, Rehner, Laura, Lohner, Szimonetta, Meerpohl, Joerg J., Nordmann, Alain, Klatte, Katharina, Ghosh, Nilabh, Heravi, Ala Taji, Wong, Jacqueline, Chow, Ngai, Hong, Patrick Jiho, Cord, Kimberly Mc, Sricharoenchai, Sirintip, Busse, Jason W., Agarwal, Arnav, Saccilotto, Ramon, Schwenkglenks, Matthias, Moffa, Giusi, Hemkens, Lars G., Hopewell, Sally, von Elm, Erik, and Briel, Matthias
- Published
- 2020
- Full Text
- View/download PDF
3. Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
- Author
-
Kasenda, Benjamin, Liu, Junhao, Jiang, Yu, Gajewski, Byron, Wu, Cen, von Elm, Erik, Schandelmaier, Stefan, Moffa, Giusi, Trelle, Sven, Schmitt, Andreas Michael, Herbrand, Amanda K., Gloy, Viktoria, Speich, Benjamin, Hopewell, Sally, Hemkens, Lars G., Sluka, Constantin, McGill, Kris, Meade, Maureen, Cook, Deborah, Lamontagne, Francois, Tréluyer, Jean-Marc, Haidich, Anna-Bettina, Ioannidis, John P. A., Treweek, Shaun, and Briel, Matthias
- Published
- 2020
- Full Text
- View/download PDF
4. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design
- Author
-
Prutsky, Gabriela J, primary, Domecq, Juan Pablo, additional, Erwin, Patricia J, additional, Briel, Matthias, additional, Montori, Victor M, additional, Akl, Elie A, additional, Meerpohl, Joerg J, additional, Bassler, Dirk, additional, Schandelmaier, Stefan, additional, Walter, Stephen D, additional, Zhou, Qi, additional, Coello, Pablo Alonso, additional, Moja, Lorenzo, additional, Walter, Martin, additional, Thorlund, Kristian, additional, Glasziou, Paul, additional, Kunz, Regina, additional, Ferreira-Gonzalez, Ignacio, additional, Busse, Jason, additional, Sun, Xin, additional, Kristiansen, Annette, additional, Kasenda, Benjamin, additional, Qasim-Agha, Osama, additional, Pagano, Gennaro, additional, Pardo-Hernandez, Hector, additional, Urrutia, Gerard, additional, Murad, Mohammad Hassan, additional, and Guyatt, Gordon, additional
- Published
- 2013
- Full Text
- View/download PDF
5. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design
- Author
-
Gerard Urrútia, Lorenzo Moja, Joerg J Meerpohl, Annette Kristiansen, Martin A. Walter, Paul Glasziou, Elie A. Akl, Kristian Thorlund, Patricia J. Erwin, Gordon H. Guyatt, Dirk Bassler, Matthias Briel, Osama Qasim-Agha, Regina Kunz, Jason W. Busse, Hector Pardo-Hernandez, Pablo Alonso Coello, Gabriela Prutsky, Gennaro Pagano, Mohammad Hassan Murad, Victor M. Montori, Benjamin Kasenda, Stephen D. Walter, Stefan Schandelmaier, Xin Sun, Ignacio Ferreira-González, Juan Pablo Domecq, and Qi Zhou
- Subjects
Research design ,medicine.medical_specialty ,Time Factors ,conflict of interest ,Alternative medicine ,Medicine (miscellaneous) ,610 Medicine & health ,data extraction ,law.invention ,Continuation ,Study Protocol ,sensitivity analysis ,Randomized controlled trial ,law ,medicine ,Relative magnitude ,Protocol ,purl.org/pe-repo/ocde/ford#1.06.02 [https] ,Humans ,Pharmacology (medical) ,randomized controlled trial (topic) ,Randomized controlled trials stopped early for benefit ,Randomized Controlled Trials as Topic ,Evidence-Based Medicine ,business.industry ,Information Dissemination ,article ,Evidence-based medicine ,journal impact factor ,publication ,clinical research ,Research Design ,Early Termination of Clinical Trials ,Physical therapy ,Systematic review ,Periodicals as Topic ,business ,RCT ,controlled vocabulary - Abstract
Background Randomized control trials (RCTs) stopped early for benefit (truncated RCTs) are increasingly common and, on average, overestimate the relative magnitude of benefit by approximately 30%. Investigators stop trials early when they consider it is no longer ethical to enroll patients in a control group. The goal of this systematic review is to determine how investigators of ongoing or planned RCTs respond to the publication of a truncated RCT addressing a similar question. Methods/design We will conduct systematic reviews to update the searches of 210 truncated RCTs to identify similar trials ongoing at the time of publication, or started subsequently, to the truncated trials ('subsequent RCTs’). Reviewers will determine in duplicate the similarity between the truncated and subsequent trials. We will analyze the epidemiology, distribution, and predictors of subsequent RCTs. We will also contact authors of subsequent trials to determine reasons for beginning, continuing, or prematurely discontinuing their own trials, and the extent to which they rely on the estimates from truncated trials. Discussion To the extent that investigators begin or continue subsequent trials they implicitly disagree with the decision to stop the truncated RCT because of an ethical mandate to administer the experimental treatment. The results of this study will help guide future decisions about when to stop RCTs early for benefit.
- Published
- 2013
- Full Text
- View/download PDF
6. Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada
- Author
-
Matthias Briel, Bernice S. Elger, Stuart McLennan, Stefan Schandelmaier, Erik von Elm, and Priya Satalkar
- Subjects
Randomized clinical trials ,Interview study ,Poor recruitment ,Reasons for recruitment failure ,Qualitative analysis ,Medicine (General) ,R5-920 - Abstract
Abstract Background Poor participant recruitment is the most frequent reason for premature discontinuation of randomized clinical trials (RCTs), particularly if they are investigator-initiated. The aims of this qualitative study were to investigate (1) the views of clinical trial stakeholders from three different countries regarding reasons for recruitment failure in RCTs and (2) how these compare and contrast with the causes identified in a previous systematic review of RCT publications. Methods From August 2015 to November 2016, we conducted 49 semi-structured interviews with a purposive sample of clinical trial stakeholders. This included investigators based in Germany (n = 9), Switzerland (n = 6) and Canada (n = 1) with personal experience of a discontinued RCT and 33 other stakeholders (e.g., representatives of ethics committees, clinical trial units, pharmaceutical industry) in Switzerland. Individual semi-structured qualitative interviews were conducted and analyzed using thematic analysis. Results Interviewees identified a total of 29 different reasons for recruitment failure. Overoptimistic recruitment estimates, too narrow eligibility criteria, lack of engagement of recruiters/trial team, lack of competence/training/experience of recruiters, insufficient initial funding, and high burden for trial participants were mentioned most frequently. The interview findings largely confirm the previous systematic review on published reasons for recruitment failure. However, eight new reasons for recruitment failure were identified in the interviews, which led to the checklist of reasons for recruitment failure being revised and a new category describing research environment-related factors being added. Conclusions This study highlights the diversity of often interlinked reasons for recruitment failure in RCTs. Integrating the findings of this interview study with a previous systematic review of RCT publications led to a comprehensive, structured checklist of empirically-informed reasons for recruitment failure. The checklist may be useful to guide further research on interventions to improve participant recruitment in RCTs and helpful for trial investigators, research ethics committees, and funding agencies when assessing trial feasibility with respect to recruitment.
- Published
- 2021
- Full Text
- View/download PDF
7. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
- Author
-
Dmitry Gryaznov, Ayodele Odutayo, Belinda von Niederhäusern, Benjamin Speich, Benjamin Kasenda, Elena Ojeda-Ruiz, Anette Blümle, Stefan Schandelmaier, Dominik Mertz, Yuki Tomonaga, Alain Amstutz, Christiane Pauli-Magnus, Viktoria Gloy, Karin Bischoff, Katharina Wollmann, Laura Rehner, Szimonetta Lohner, Joerg J. Meerpohl, Alain Nordmann, Katharina Klatte, Nilabh Ghosh, Ala Taji Heravi, Jacqueline Wong, Ngai Chow, Patrick Jiho Hong, Kimberly Mc Cord, Sirintip Sricharoenchai, Jason W. Busse, Arnav Agarwal, Ramon Saccilotto, Matthias Schwenkglenks, Giusi Moffa, Lars G. Hemkens, Sally Hopewell, Erik von Elm, and Matthias Briel
- Subjects
Randomized clinical trials ,Trial protocol ,Reporting quality ,Reporting guideline adherence ,Registration ,Trial discontinuation ,Medicine (General) ,R5-920 - Abstract
Abstract Background Clearly structured and comprehensive protocols are an essential component to ensure safety of participants, data validity, successful conduct, and credibility of results of randomized clinical trials (RCTs). Funding agencies, research ethics committees (RECs), regulatory agencies, medical journals, systematic reviewers, and other stakeholders rely on protocols to appraise the conduct and reporting of RCTs. In response to evidence of poor protocol quality, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guideline was published in 2013 to improve the accuracy and completeness of clinical trial protocols. The impact of these recommendations on protocol completeness and associations between protocol completeness and successful RCT conduct and publication remain uncertain. Objectives and methods Aims of the Adherence to SPIrit REcommendations (ASPIRE) study are to investigate adherence to SPIRIT checklist items of RCT protocols approved by RECs in the UK, Switzerland, Germany, and Canada before (2012) and after (2016) the publication of the SPIRIT guidelines; determine protocol features associated with non-adherence to SPIRIT checklist items; and assess potential differences in adherence across countries. We assembled an international cohort of RCTs based on 450 protocols approved in 2012 and 402 protocols approved in 2016 by RECs in Switzerland, the UK, Germany, and Canada. We will extract data on RCT characteristics and adherence to SPIRIT for all included protocols. We will use multivariable regression models to investigate temporal changes in SPIRIT adherence, differences across countries, and associations between SPIRIT adherence of protocols with RCT registration, completion, and publication of results. We plan substudies to examine the registration, premature discontinuation, and non-publication of RCTs; the use of patient-reported outcomes in RCT protocols; SPIRIT adherence of RCT protocols with non-regulated interventions; the planning of RCT subgroup analyses; and the use of routinely collected data for RCTs. Discussion The ASPIRE study and associated substudies will provide important information on the impact of measures to improve the reporting of RCT protocols and on multiple aspects of RCT design, trial registration, premature discontinuation, and non-publication of RCTs observing potential changes over time.
- Published
- 2020
- Full Text
- View/download PDF
8. Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
- Author
-
Benjamin Kasenda, Junhao Liu, Yu Jiang, Byron Gajewski, Cen Wu, Erik von Elm, Stefan Schandelmaier, Giusi Moffa, Sven Trelle, Andreas Michael Schmitt, Amanda K. Herbrand, Viktoria Gloy, Benjamin Speich, Sally Hopewell, Lars G. Hemkens, Constantin Sluka, Kris McGill, Maureen Meade, Deborah Cook, Francois Lamontagne, Jean-Marc Tréluyer, Anna-Bettina Haidich, John P. A. Ioannidis, Shaun Treweek, and Matthias Briel
- Subjects
Recruitment ,Accrual ,Prediction ,Randomized clinical trials ,Medicine (General) ,R5-920 - Abstract
Abstract Background Poor recruitment of patients is the predominant reason for early termination of randomized clinical trials (RCTs). Systematic empirical investigations and validation studies of existing recruitment models, however, are lacking. We aim to provide evidence-based guidance on how to predict and monitor recruitment of patients into RCTs. Our specific objectives are the following: (1) to establish a large sample of RCTs (target n = 300) with individual patient recruitment data from a large variety of RCTs, (2) to investigate participant recruitment patterns and study site recruitment patterns and their association with the overall recruitment process, (3) to investigate the validity of a freely available recruitment model, and (4) to develop a user-friendly tool to assist trial investigators in the planning and monitoring of the recruitment process. Methods Eligible RCTs need to have completed the recruitment process, used a parallel group design, and investigated any healthcare intervention where participants had the free choice to participate. To establish the planned sample of RCTs, we will use our contacts to national and international RCT networks, clinical trial units, and individual trial investigators. From included RCTs, we will collect patient-level information (date of randomization), site-level information (date of trial site activation), and trial-level information (target sample size). We will examine recruitment patterns using recruitment trajectories and stratifications by RCT characteristics. We will investigate associations of early recruitment patterns with overall recruitment by correlation and multivariable regression. To examine the validity of a freely available Bayesian prediction model, we will compare model predictions to collected empirical data of included RCTs. Finally, we will user-test any promising tool using qualitative methods for further tool improvement. Discussion This research will contribute to a better understanding of participant recruitment to RCTs, which could enhance efficiency and reduce the waste of resources in clinical research with a comprehensive, concerted, international effort.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.